Skip to main content

Table 1 The summary statistics for 18 meta-analyses carried out by the MAG.

From: Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Qstatistics

Meta-analysis # trials Q, P-value (%) Fixed Effect HR (CI) P-value
cervix 1 [15] 18 44.48, 0.00 62 1.05 (0.93-1.19) 0.39
cervix 2 [17] 18 20.83 0.23 18 0.76 (0.67-0.85) 0.00
cervix 3 [15] 5 9.18, 0.06 56 0.65 (0.53-0.80) 0.00
bladder 1 [14] 9 7.27, 0.51 0 0.91 (0.83-1.01) 0.08
bladder 2 [16] 6 2.25, 0.81 0 0.75 (0.60-0.96) 0.02
nsclc 1 [8] 17 28.98, 0.02 45 1.04 (0.96-1.12) 0.33
nsclc 2 [8] 7 3.63, 0.73 0 0.98 (0.83-1.14) 0.76
nsclc 3 [8] 25 22.32, 0.56 0 0.90 (0.83-0.97) 0.01
nsclc 4 [8] 11 39.63, 0.00 75 0.84 (0.74-0.95) 0.01
ovarian 1 [7] 19 21.92, 0.24 18 0.98 (0.91-1.06) 0.69
ovarian 2 [7] 11 12.83, 0.23 22 0.93 (0.83-1.05) 0.23
ovarian 3 [10] 9 14.78, 0.06 46 0.88 (0.79-0.98) 0.02
ovarian 4 [10] 9 10.35, 0.24 23 0.91 (0.80-1.05) 0.21
ovarian 5 [10] 12 2.57, 1.00 0 1.02 (0.93-1.12) 0.66
port [11] 9 13.06, 0.11 39 1.21 (1.08-1.34) 0.00
sarcoma [9] 14 11.80, 0.54 0 0.89 (0.76-1.03) 0.12
oeso [12] 6 10.37, 0.07 52 0.89 (0.78-1.01) 0.06
glioma [13] 12 13.29, 0.27 17 0.85 (0.78-0.92) 0.00